PTGS2 and colorectal neoplasm: Aberrant DNA methylation of the COX-2 CpG islands was first reported in colorectal tumors [31], and DNA hypermethylation of COX-2 at its promoter was shown to be related to COX-2 gene silencing [20, 21].